Core Viewpoint - The company has developed a full-process traceability platform for fentanyl-based drugs in collaboration with Huazhong University of Science and Technology, addressing significant management challenges in medical institutions [1][2] Group 1: Platform Development - The platform is designed to provide a closed-loop management solution that complies with national standards, currently tested at the main campus of Huazhong University of Science and Technology [1] - It integrates unique identification codes for each drug, along with smart destruction cabinets and handheld PDAs, enabling real-time data interconnection and cross-verification throughout the drug lifecycle [1][2] Group 2: Management Challenges - Medical institutions face multiple challenges in managing fentanyl drugs, particularly in the complex three-tier management system from the pharmacy to clinical departments, where large quantities and complicated processes complicate oversight [1] - The platform addresses key pain points, including system disconnection, vague handling of leftover liquid, and ensuring traceability of medical actions in high-risk scenarios [2] Group 3: Technological Integration - The platform incorporates drug traceability coding technology aligned with industry standards, ensuring compliance and professional integrity [2] - It is compatible with domestic operating systems such as Tongxin UOS, open-source Hongmeng, and Hongzhi OS, utilizing IoT technology for real-time data uploads and dynamic monitoring of drug flow [2] - Blockchain technology is employed to ensure data integrity and prevent tampering, enhancing the overall security of the management process [2] Group 4: Implementation Results - Initial testing at Huazhong University of Science and Technology has shown positive results, achieving the goal of replacing traditional manual verification with technological solutions, thereby improving drug management efficiency and safety [2]